229 related articles for article (PubMed ID: 21427395)
1. Childhood mortality in a cohort treated with mass azithromycin for trachoma.
Keenan JD; Ayele B; Gebre T; Zerihun M; Zhou Z; House JI; Gaynor BD; Porco TC; Emerson PM; Lietman TM
Clin Infect Dis; 2011 Apr; 52(7):883-8. PubMed ID: 21427395
[TBL] [Abstract][Full Text] [Related]
2. Effect of mass distribution of azithromycin for trachoma control on overall mortality in Ethiopian children: a randomized trial.
Porco TC; Gebre T; Ayele B; House J; Keenan J; Zhou Z; Hong KC; Stoller N; Ray KJ; Emerson P; Gaynor BD; Lietman TM
JAMA; 2009 Sep; 302(9):962-8. PubMed ID: 19724043
[TBL] [Abstract][Full Text] [Related]
3. Risk factors for ocular chlamydia after three mass azithromycin distributions.
Ayele B; Gebre T; Moncada J; House JI; Stoller NE; Zhou Z; Porco TC; Gaynor BD; Emerson PM; Schachter J; Keenan JD
PLoS Negl Trop Dis; 2011 Dec; 5(12):e1441. PubMed ID: 22180804
[TBL] [Abstract][Full Text] [Related]
4. A Longitudinal Analysis of Chlamydial Infection and Trachomatous Inflammation Following Mass Azithromycin Distribution.
Morberg DP; Alemayehu W; Melese M; Lakew T; Sisay A; Zhou Z; Cevallos V; Oldenburg CE; Porco TC; Lietman TM; Keenan JD
Ophthalmic Epidemiol; 2019 Feb; 26(1):19-26. PubMed ID: 30153085
[TBL] [Abstract][Full Text] [Related]
5. Childhood Mortality After Mass Distribution of Azithromycin: A Secondary Analysis of the PRET Cluster-randomized Trial in Niger.
O'Brien KS; Cotter SY; Amza A; Kadri B; Nassirou B; Stoller NE; Zhou Z; West SK; Bailey RL; Keenan JD; Porco TC; Lietman TM
Pediatr Infect Dis J; 2018 Nov; 37(11):1082-1086. PubMed ID: 29561511
[TBL] [Abstract][Full Text] [Related]
6. Complete local elimination of infectious trachoma from severely affected communities after six biannual mass azithromycin distributions.
Biebesheimer JB; House J; Hong KC; Lakew T; Alemayehu W; Zhou Z; Moncada J; Rogér A; Keenan J; Gaynor BD; Schachter J; Lietman TM
Ophthalmology; 2009 Nov; 116(11):2047-50. PubMed ID: 19744717
[TBL] [Abstract][Full Text] [Related]
7. Comparison of annual and biannual mass antibiotic administration for elimination of infectious trachoma.
Melese M; Alemayehu W; Lakew T; Yi E; House J; Chidambaram JD; Zhou Z; Cevallos V; Ray K; Hong KC; Porco TC; Phan I; Zaidi A; Gaynor BD; Whitcher JP; Lietman TM
JAMA; 2008 Feb; 299(7):778-84. PubMed ID: 18285589
[TBL] [Abstract][Full Text] [Related]
8. Comparison of annual versus twice-yearly mass azithromycin treatment for hyperendemic trachoma in Ethiopia: a cluster-randomised trial.
Gebre T; Ayele B; Zerihun M; Genet A; Stoller NE; Zhou Z; House JI; Yu SN; Ray KJ; Emerson PM; Keenan JD; Porco TC; Lietman TM; Gaynor BD
Lancet; 2012 Jan; 379(9811):143-51. PubMed ID: 22192488
[TBL] [Abstract][Full Text] [Related]
9. Mass azithromycin distribution for hyperendemic trachoma following a cluster-randomized trial: A continuation study of randomly reassigned subclusters (TANA II).
Keenan JD; Tadesse Z; Gebresillasie S; Shiferaw A; Zerihun M; Emerson PM; Callahan K; Cotter SY; Stoller NE; Porco TC; Oldenburg CE; Lietman TM
PLoS Med; 2018 Aug; 15(8):e1002633. PubMed ID: 30106956
[TBL] [Abstract][Full Text] [Related]
10. Trachoma and ocular Chlamydia trachomatis were not eliminated three years after two rounds of mass treatment in a trachoma hyperendemic village.
West SK; Munoz B; Mkocha H; Gaydos C; Quinn T
Invest Ophthalmol Vis Sci; 2007 Apr; 48(4):1492-7. PubMed ID: 17389476
[TBL] [Abstract][Full Text] [Related]
11. Coverage of azithromycin mass treatment for trachoma elimination in Northwestern Ethiopia: a community based cross-sectional study.
Tilahun Z; Fenta TG
BMC Ophthalmol; 2018 Aug; 18(1):193. PubMed ID: 30081851
[TBL] [Abstract][Full Text] [Related]
12. Comparison of Mass Azithromycin Coverage Targets of Children in Niger: A Cluster-Randomized Trachoma Trial.
Oldenburg CE; Amza A; Kadri B; Nassirou B; Cotter SY; Stoller NE; West SK; Bailey RL; Porco TC; Gaynor BD; Keenan JD; Lietman TM
Am J Trop Med Hyg; 2018 Feb; 98(2):389-395. PubMed ID: 29260659
[TBL] [Abstract][Full Text] [Related]
13. Assessment of herd protection against trachoma due to repeated mass antibiotic distributions: a cluster-randomised trial.
House JI; Ayele B; Porco TC; Zhou Z; Hong KC; Gebre T; Ray KJ; Keenan JD; Stoller NE; Whitcher JP; Gaynor BD; Emerson PM; Lietman TM
Lancet; 2009 Mar; 373(9669):1111-8. PubMed ID: 19329003
[TBL] [Abstract][Full Text] [Related]
14. Linear growth in preschool children treated with mass azithromycin distributions for trachoma: A cluster-randomized trial.
Keenan JD; Gebresillasie S; Stoller NE; Haile BA; Tadesse Z; Cotter SY; Ray KJ; Aiemjoy K; Porco TC; Callahan EK; Emerson PM; Lietman TM
PLoS Negl Trop Dis; 2019 Jun; 13(6):e0007442. PubMed ID: 31166952
[TBL] [Abstract][Full Text] [Related]
15. Risk factors for active trachoma and Chlamydia trachomatis infection in rural Ethiopia after mass treatment with azithromycin.
Edwards T; Harding-Esch EM; Hailu G; Andreason A; Mabey DC; Todd J; Cumberland P
Trop Med Int Health; 2008 Apr; 13(4):556-65. PubMed ID: 18282237
[TBL] [Abstract][Full Text] [Related]
16. Thinking deeper about important mass treatment trials.
Guerrant RL; Bartelt LA; Scharf RJ
Clin Infect Dis; 2012 Jun; 54(11):1674-5. PubMed ID: 22431805
[No Abstract] [Full Text] [Related]
17. Mass Oral Azithromycin for Childhood Mortality: Timing of Death After Distribution in the MORDOR Trial.
Porco TC; Hart J; Arzika AM; Weaver J; Kalua K; Mrango Z; Cotter SY; Stoller NE; O'Brien KS; Fry DM; Vanderschelden B; Oldenburg CE; West SK; Bailey RL; Keenan JD; Lietman TM;
Clin Infect Dis; 2019 May; 68(12):2114-2116. PubMed ID: 30561577
[TBL] [Abstract][Full Text] [Related]
18. Antibiotics for trachoma.
Evans JR; Solomon AW
Cochrane Database Syst Rev; 2011 Mar; (3):CD001860. PubMed ID: 21412875
[TBL] [Abstract][Full Text] [Related]
19. Prevalence of Active and Latent Yaws in the Solomon Islands 18 Months after Azithromycin Mass Drug Administration for Trachoma.
Marks M; Sokana O; Nachamkin E; Puiahi E; Kilua G; Pillay A; Bottomley C; Solomon AW; Mabey DC
PLoS Negl Trop Dis; 2016 Aug; 10(8):e0004927. PubMed ID: 27551787
[TBL] [Abstract][Full Text] [Related]
20. Mass distribution of azithromycin for trachoma control is associated with short-term reduction in risk of acute lower respiratory infection in young children.
Coles CL; Levens J; Seidman JC; Mkocha H; Munoz B; West S
Pediatr Infect Dis J; 2012 Apr; 31(4):341-6. PubMed ID: 22173140
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
